4.52
-0.18 (-3.83%)
-0.18 (-3.83%)
Upgrade to Real-Time
Afterhours
Low
3.15
High
9.00
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Zynerba Pharmaceuticals Inc | ZYNE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.18 | -3.83% | 4.52 | 17:16:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.71 | 4.52 | 4.72 | 4.53 | 4.70 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 4.52 | 4.75 | 0.23 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,689 | 403,735 | $ 4.60 | $ 1,858,377 | - | 3.15 - 9.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:16:00 | formt | 278 | $ 4.52 | USD |
Period:
Draw Mode:
Zynerba Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 186.46M | 41.25M | 39.99M | $ - | $ - | -1.93 | -2.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 5.90% |
Zynerba Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ZYNE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.82 | 4.82 | 4.325 | 4.58 | 690,592 | -0.30 | -6.22% |
| 1 Month | 5.30 | 5.39 | 4.325 | 4.82 | 540,148 | -0.78 | -14.72% |
| 3 Months | 4.43 | 6.07 | 3.91 | 5.03 | 1,299,033 | 0.09 | 2.03% |
| 6 Months | 3.54 | 9.00 | 3.40 | 5.31 | 3,340,198 | 0.98 | 27.68% |
| 1 Year | 3.80 | 9.00 | 3.15 | 5.00 | 2,029,465 | 0.72 | 18.95% |
| 3 Years | 7.02 | 16.47 | 2.55 | 6.49 | 1,404,165 | -2.50 | -35.61% |
| 5 Years | 8.30 | 25.95 | 2.55 | 7.58 | 1,025,947 | -3.78 | -45.54% |
Zynerba Pharmaceuticals Description
| Zynerba Pharmaceuticals Inc is a pharmaceutical company that is focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product pipeline consists Zygel which is a pharmaceutically-produced CBD, a non-euphoric cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system. |
